Following research at Imperial College, we believe we’ve found a novel and effective treatment for relapsed/resistant cancer, targeting and killing cancer stem cells. With patents in place, we now need funding for the next phase: to complete lab-testing prior to clinical trials.
Research and experimental development on biotechnology
|Date||Amount||No. of Investors|
|COHEN, Laurence John||Director||17/05/2017||British|
|DEONARAIN, Mahendra Persaud, Dr||Director||19/04/2019||British|
|EPENETOS, Agamemnon Antoniou, Dr||Director||16/11/2016||British|